Phase II Study Of Decitabine In Patients With Metastatic Papillary Thyroid Cancer Or Follicular Thyroid Cancer Unresponsive To Radioiodine.

Trial Profile

Phase II Study Of Decitabine In Patients With Metastatic Papillary Thyroid Cancer Or Follicular Thyroid Cancer Unresponsive To Radioiodine.

Completed
Phase of Trial: Phase II

Latest Information Update: 29 Aug 2014

At a glance

  • Drugs Decitabine (Primary) ; Fludeoxyglucose F-18; Iodine-131; Liothyronine; Thyrotropin alfa
  • Indications Thyroid cancer
  • Focus Therapeutic Use
  • Most Recent Events

    • 27 Aug 2013 Planned end date changed from 1 Jan 2013 to 1 Jan 2014 as reported by ClinicalTrials.gov.
    • 01 Apr 2013 Status changed from suspended to active, no longer recruiting as reported by ClinicalTrials.gov.
    • 02 Jan 2013 Status changed from active, no longer recruiting to suspended as reported by ClinicalTrials.gov.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top